Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dhingra

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Journal of Biomolecular Structure & Dynamics|October 1, 1983
Poly(dA-dT).poly(dA-dT) in low salt appears to be a left-handed B-helix combined use of chemical theory, fiber diffraction and NMR spectroscopyG Gupta, M H Sarma, M M Dhingra, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesotheliomaH M Dhingra, W K Murphy, R J Winn, et al.
Investigational New Drugs|February 1, 1991
A phase I trial of recombinant alpha-2a interferon (Roferon-A) with weekly cisplatinumK Dhingra, M Talpaz, H M Dhingra, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|April 29, 1998
Comparative conformational studies on cyclic hexapeptides corresponding to message sequence His-Phe-Arg-Trp of alpha-melanotropin by NMRM S Prachand, M M Dhingra, A Saran, et al.
Cancer Treatment Reports|September 1, 1987
Phase II study of 5,6-dihydro-5-azacytidine in extensive, untreated non-small cell lung cancerP Y Holoye, H M Dhingra, T Umsawasdi, et al.
Cancer Treatment Reports|April 1, 1986
I.v. melphalan in carcinoma of the lung: effect of cyclophosphamide priming on hematopoietic toxicityG Spitzer, M Valdivieso, P Farha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Primary chemotherapy of brain metastasis in small-cell lung cancerJ S Lee, W K Murphy, B S Glisson, et al.
American Journal of Clinical Oncology|June 1, 1984
Phase II clinical evaluation of dihydroxyanthracenedione in patients with advanced lung cancerM Valdivieso, T Umsawasdi, G Spitzer, et al.
American Journal of Clinical Oncology|June 1, 1992
Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancerD M Shin, H M Dhingra, J S Lee, et al.
Cancer Treatment Reports|May 1, 1986
Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancerH M Dhingra, T Umsawasdi, D F Chiuten, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Journal of Biomolecular Structure & Dynamics|October 1, 1983
Poly(dA-dT).poly(dA-dT) in low salt appears to be a left-handed B-helix combined use of chemical theory, fiber diffraction and NMR spectroscopyG Gupta, M H Sarma, M M Dhingra, et al.
Investigational New Drugs|February 1, 1991
Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesotheliomaH M Dhingra, W K Murphy, R J Winn, et al.
Investigational New Drugs|February 1, 1991
A phase I trial of recombinant alpha-2a interferon (Roferon-A) with weekly cisplatinumK Dhingra, M Talpaz, H M Dhingra, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|April 29, 1998
Comparative conformational studies on cyclic hexapeptides corresponding to message sequence His-Phe-Arg-Trp of alpha-melanotropin by NMRM S Prachand, M M Dhingra, A Saran, et al.
Cancer Treatment Reports|September 1, 1987
Phase II study of 5,6-dihydro-5-azacytidine in extensive, untreated non-small cell lung cancerP Y Holoye, H M Dhingra, T Umsawasdi, et al.
Cancer Treatment Reports|April 1, 1986
I.v. melphalan in carcinoma of the lung: effect of cyclophosphamide priming on hematopoietic toxicityG Spitzer, M Valdivieso, P Farha, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Primary chemotherapy of brain metastasis in small-cell lung cancerJ S Lee, W K Murphy, B S Glisson, et al.
American Journal of Clinical Oncology|June 1, 1984
Phase II clinical evaluation of dihydroxyanthracenedione in patients with advanced lung cancerM Valdivieso, T Umsawasdi, G Spitzer, et al.
American Journal of Clinical Oncology|June 1, 1992
Phase II study of combination therapy with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small-cell lung cancerD M Shin, H M Dhingra, J S Lee, et al.
Cancer Treatment Reports|May 1, 1986
Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancerH M Dhingra, T Umsawasdi, D F Chiuten, et al.
Pageof 7